Indonesian Political, Business & Finance News

BPOM and EDQM join forces to improve Indonesian drug quality and competitiveness

| Source: Antara (English) | Regulation
BPOM and EDQM join forces to improve Indonesian drug quality and competitiveness
Image: Antara (English)

“For Indonesia, this cooperation is expected to provide long-term benefits, both in strengthening public health protection through increasingly reliable drug quality oversight and supporting the national pharmaceutical industry’s readiness to meet international quality standards,” BPOM Head Taruna Ikrar said here on Friday (Nov 13).

Ikrar assessed that aligned standards could also improve the competitiveness of Indonesian pharmaceutical products in the global market.

“We want this cooperation to produce real steps, not just agreements on paper. The hope is that Indonesia can contribute more actively to developing world drug standards while benefiting the progress of the national pharmaceutical industry,” he added.

Related news: Ministry, BPOM strengthen downstreaming of natural medicine research

Ikrar explained the five-year strategic cooperation focuses on strengthening quality standards for drugs and drug substances, supporting development of the Indonesian Pharmacopoeia, exchanging technical information, as well as improving access to international testing knowledge and standards.

The memorandum of understanding (MoU) was signed through a desk-to-desk signing mechanism. Ikrar signed the document in Jakarta on October 1, 2026, and EDQM Director Petra Doerr signed it in Strasbourg, France, on October 20, 2026.

The BPOM will also draft a plan of action with the EDQM to turn the agreement into more concrete technical activities, focusing on drug quality standards, testing method development, laboratory competence, and Indonesia’s possible participation in international standardization programs.

The collaboration also complements Indonesia’s ongoing efforts to strengthen drug oversight, including after BPOM was recognized as a World Health Organization (WHO)-Listed Authority for vaccines.

Through international cooperation and scientific advances, BPOM is committed to improving oversight capacity and ensuring the public gets safe, effective, and quality drugs.

Related news: Biosimilar development key to strengthen national manufacturing: BPOM

Related news: Indonesia, Russia explore drug technology transfers to cut imports

Translator: Mecca, Kenzu

More from 14 November 2026 →

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/bpom-and-edqm-join-forces-to-improve-indonesian-drug-quality-and-competitiveness-1794653438)
Originally published by Antara (English) (https://en.antaranews.com/news/442651/bpom-edqm-team-up-to-boost-indonesian-drug-quality-competitiveness)
Print